Thomas R. Arkell

1.2k citations
27 papers · 759 · h-index 13

Impact in

  • Toxicology top 1%
    • Forensic Toxicology and Drug Analysis
    • Cannabis and Cannabinoid Research

Papers in

    • Cannabis and Cannabinoid Research 23
    • Coffee research and impacts 1
    • Forensic Toxicology and Drug Analysis 7

Thomas R. Arkell

25 papers receiving 747 citations

Peers

Thomas R. Arkell
Comparison fields: 5 of 67
  • Toxicology 140
  • Pharmacology 625
  • Cognitive Neuroscience 76
  • Experimental and Cognitive Psychology 50
  • Endocrine and Autonomic Systems 24
Replace Nicolas J. Schlienz with:
Nicolas J. Schlienz United States
Mallory Loflin United States
Ronald Flegel United States
Shanna Babalonis United States
Erhard Schneider Germany
Katherine Papafotiou Australia
Caroline A. MacCallum Canada
Pamela Sabioni Canada
Andrew Spurgin United States
Mark Montebello Australia
Thomas R. Arkell relative to Nicolas J. Schlienz United States Nicolas J. Schlienz's profile →
Citations per field
00.5×1.5×2.2×
Nicolas J. Schlienz · 1×
Citations per year

Countries citing papers authored by Thomas R. Arkell

Since Specialization
Citations

This map shows the geographic impact of Thomas R. Arkell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Arkell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Arkell more than expected).

Fields of papers citing papers by Thomas R. Arkell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Arkell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Arkell. The network helps show where Thomas R. Arkell may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas R. Arkell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas R. Arkell Line = papers co-authored together Thomas R. Arkell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019133
2 2021116
3 2020111
4 202083
5 202141
6 202140
7 201932
8 202332
9 202029
10 202128
11 202124
12 202213
13 202013
14 20239
15 20249
16 20228
17 20248
18 20235
19 20205
20 20225

About Thomas R. Arkell

Thomas R. Arkell is a scholar working on Pharmacology, Toxicology, Epidemiology, Pediatrics, Perinatology and Child Health and Cognitive Neuroscience, having authored 27 papers that have together received 759 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (23 papers), Forensic Toxicology and Drug Analysis (7 papers), Substance Abuse Treatment and Outcomes (5 papers), Prenatal Substance Exposure Effects (3 papers), Sleep and Wakefulness Research (3 papers), Behavioral Health and Interventions (1 paper), Coffee research and impacts (1 paper) and Bipolar Disorder and Treatment (1 paper). The work is most often cited by research in Toxicology (140 citations), Pharmacology (625 citations), Cognitive Neuroscience (76 citations), Experimental and Cognitive Psychology (50 citations) and Endocrine and Autonomic Systems (24 citations). Thomas R. Arkell has collaborated with scholars based in Australia, Netherlands and United States. Frequent co-authors include Iain S. McGregor, Richard C. Kevin, Christopher Irwin, Danielle McCartney, Johannes G. Ramaekers, Nicholas Lintzeris, Ryan G. Vandrey, Eef L. Theunissen, Frederick Vinckenbosch and Paul Haber. Their work appears in journals such as Neuroscience & Biobehavioral Reviews, Addiction Biology, Harm Reduction Journal, Journal of Psychopharmacology and Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact